Anzela Niraula, Ph.D., of the University of Washington in Seattle, won the Endocrine Society’s 2023 Endocrine Images Art Competition for her image of the microglia mandala. This contest celebrates the beauty of endocrine science, and entries were judged based on aesthetic value and significance to endocrine research.
Tag: Endocrinology
Endocrine Society alarmed by Texas court ruling banning mifepristone
The Endocrine Society is deeply concerned about a Texas ruling that reverses the U.S. Food and Drug Administration’s (FDA) approval of mifepristone, a drug used to treat Cushing’s syndrome and to end pregnancy safely and effectively.
Endocrine Society supports EPA rule regulating “forever chemicals” in drinking water
The Endocrine Society supports a new U.S. Environmental Protection Agency (EPA) rule which includes provisions to regulate several per- and polyfluoroalkyl substances (PFAS)—including PFOA and PFOS—found in our drinking water.
Response to hormone therapy predicts radiation resistance in ER+ breast cancer
How estrogen receptor-positive (ER+) breast cancer responds to hormone therapy may hold keys to understanding how it will respond to radiation therapy, and an experimental drug that increases the effectiveness of hormone therapy also overcomes radiation resistance in breast cancer, a study by UT Southwestern Medical Center researchers shows.
Endocrine Society applauds Eli Lilly’s efforts to lower insulin costs
The Endocrine Society commends Eli Lilly and Company for taking steps to reduce insulin prices and make insulin affordable for more people with diabetes.
Phase 3 Trial Finds Oral Empagliflozin Provided Safe Glycemic Control in Children with Type 2 Diabetes
Researchers recently completed a phase 3 clinical trial that assessed the efficacy and safety of two different classes of oral agents for the treatment of type 2 diabetes in young people aged 10-17 years.
Improving Surgical Outcomes for Children With Rickets
A new study finds that metabolic control after surgery is associated with successful correction of leg deformities in children with hypophosphatemic rickets. Orthopedic surgery plays a critical role in the treatment of angular deformities in children with severe forms of hypophosphatemic rickets, a rare disorder that leads to soft, painful bones and poor growth.
Autoantibody linked to rare disorder that destroys fat, UT Southwestern researchers find
Researchers at UT Southwestern Medical Center have discovered the first molecular biomarker for acquired generalized lipodystrophy (AGL), a rare disorder in which fat deposits are destroyed, causing patients to have dangerously low body fat, signs of accelerated aging, and severe metabolic diseases including diabetes and fatty liver.
Phthalate exposure may increase diabetes risk in women
Endocrine-disrupting chemicals (EDCs) in plastics may contribute to diabetes risk in women, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
Endocrine Society praises State of the Union attention to insulin affordability
The Endocrine Society applauds President Biden’s call to rein in soaring insulin prices for those with private insurance and urges Congress to take immediate action.
Endocrine Society awards Baxter Prize to innovator in endocrine drug discovery
R. Scott Struthers, Ph.D., has been awarded the Endocrine Society’s John D. Baxter Prize for Entrepreneurship for his contributions to drug discovery and development programs for endocrine diseases, the Society announced today.
Media registration open for ENDO 2023
Members of the media can now register to cover the latest advances in hormone health and science at ENDO 2023, the Endocrine Society’s annual meeting being held June 15-18, in Chicago, Illinois.
Experts explain treatment options for a common cancer complication
Experts provide the first framework for treating a common and life-threatening metabolic complication of cancer known as hypercalcemia of malignancy in the Endocrine Society’s new Clinical Practice Guideline.
Researchers discover rare form of premature-aging syndrome
UT Southwestern researchers have discovered a new form of progeria, a rare premature-aging syndrome, in a man from Malaysia and traced its cause to a novel gene mutation.
New Endocrine Society Clinical Practice Guideline examines better ways to manage hypoglycemia in people with diabetes
People with diabetes are benefiting from advances in medications and technologies to lower their risk of hypoglycemia, according to a Clinical Practice Guideline issued today by the Endocrine Society.
People with diabetes may benefit more from a pancreas transplant than other treatments
Results of pancreas transplantation continue to improve and up to 90% of recipients with diabetes enjoy freedom from both insulin therapy and the need for close glucose monitoring following the procedure, according to a new paper published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
Chrousos named winner of Transatlantic Alliance Award
The Endocrine Society and the European Society of Endocrinology (ESE) have jointly awarded the 2023 Transatlantic Alliance Award—to Prof. George P. Chrousos, M.D., Sc.D.
Endocrine Society honors endocrinology field’s leaders with 2023 Laureate Awards
The Endocrine Society today announced it has chosen 13 leading endocrinologists as winners of its prestigious 2023 Laureate Awards, the top honors in the field.
Endocrine Society experts recommend individualized approach to use of telehealth
Following rapid growth during the COVID-19 pandemic, telehealth visits are expected to remain an important part of endocrine care, according to a new Endocrine Society policy perspective published in The Journal of Clinical Endocrinology & Metabolism.
Pregnant women with obesity and diabetes may be more likely to have a child with ADHD
Children of women with gestational diabetes and obesity may be twice as likely to develop attention-deficit/hyperactivity disorder (ADHD) compared to those whose mothers did not have obesity, according to new research published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
Endocrine Society hires Meyers as Chief Strategy Officer
The Endocrine Society has hired Steven R. Meyers, PhD—an association executive with more than a decade of experience in strategic thinking and transforming and expanding operations—to serve as its Chief Strategy Officer.
Significant Boost in Rates of Type 2 Diabetes Among Children During COVID-19 Pandemic
In a multi-site study of medical records, researchers at Johns Hopkins Children’s Center and across the United States say they have documented a steep rise in type 2 diabetes among children during the COVID-19 pandemic.
Vegans who lift weights may have stronger bones than other people on a plant-based diet
People on a plant-based diet who do strength training as opposed to other forms of exercise such as biking or swimming may have stronger bones than other people on a vegan diet, according to new research published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
People with poor sleep behaviors may be at risk for fatty liver disease
People with sedentary lifestyles and unhealthy sleep behaviors could develop fatty liver disease, according to new research published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
Gut microbe peptide implicated in triggering type 1 diabetes
Researchers have identified a species of human gut bacterium that makes a protein containing a sequence of amino acids that mimics the insulin peptide targeted by the immune system in type 1 diabetes.
Endocrine Society Journals earn higher Impact Factors for 2021
The Endocrine Society’s Journals experienced sizeable Impact Factor gains, led by Endocrine Reviews, according to Clarivate’s recently released annual Journal Citation Report (JCR) for 2021.
Growth hormone improves liver health in people with nonalcoholic fatty liver disease
Growth hormone improves liver health in patients with nonalcoholic fatty liver disease (NAFLD) by reducing liver fat and inflammation, according to a new study presented Tuesday, June 14 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Study finds disparities in access to insulin pumps among youth with type 1 diabetes
Over the past 20 years, despite the overall increase in the use of insulin pumps, there have been few improvements in the ethnic, racial and socioeconomic inequities in insulin pump use among youth with type 1 diabetes, according to a new study presented Tuesday, June 14 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Children’s Hospital Los Angeles: The Best Care for Kids in California and the West Coast
U.S. News has again ranked CHLA as the top children’s hospital in California and in the survey’s Pacific U.S. region—which encompasses Alaska, California, Hawaii, Oregon and Washington. CHLA also made the publication’s annual Honor Roll of Best Children’s Hospitals for the 14th consecutive year—every year since its inception—finishing No. 8 in the United States in this showcase of the nation’s leading destinations for pediatric medical care.
Pediatric Liver Disease Increases Risk of Developing Type 2 Diabetes
UC San Diego researchers describe connection between pediatric liver disease and increased risk of developing type 2 diabetes. Both rates are rising in children.
Researchers develop pancreatic beta-cell restoring therapy for treating type 1 diabetes
Researchers have successfully treated type 1 diabetes in mice using pancreatic beta-cell, target-specific, chimeric antigen-receptor (CAR) regulatory T cells (Tregs), and demonstrated the feasibility of their approach to treat the human condition according to data being presented Monday, June 13 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Study finds long-term 10% weight loss with anti-obesity medications and lifestyle changes
A new study finds overweight and obese people maintained an average weight loss of 10.6% over 3 to 5 years with a program of lifestyle changes in combination with anti-obesity medications. Weight loss of more than 10% provides significant health benefits, according to researchers who are presenting their findings Sunday, June 12 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
People who consume too much high fructose corn syrup could be at risk for NAFLD
High fructose consumption should be avoided to prevent the development of non-alcoholic fatty liver disease (NAFLD), according to research being presented Sunday, June 12 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Moderation may disrupt addictive nature of wireless mobile devices and adverse health outcomes
Encouraging moderation, balance and real-life engagement coupled with education may combat the overuse of wireless mobile devices and subsequent adverse health outcomes, according to research being presented Sunday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Addressing stress and postpartum symptoms early may reduce risk for type 2 diabetes in women with gestational diabetes
Addressing stress early on in postpartum women who recently experienced gestational diabetes might help curb an increased risk for type 2 diabetes, according to research being presented Sunday, June 12 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
East Coast is home to greatest hot spots for diabetes complications
The East Coast of the United States, especially Florida, and Texas have some of the greatest hot spots for long-term diabetes complications, according to research being presented Sunday, June 12 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Study links diabetes and worse outcomes in long-term survivors of metastatic breast cancer
Women who are longer-term survivors of metastatic breast cancer may have a worse survival rate if they have diabetes and poorly controlled blood sugar levels, according to a new study presented Sunday, June 12 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Empagliflozin may decrease risk of kidney stones in people with diabetes
The diabetes drug empagliflozin may decrease the risk of kidney stones in patients with type 2 diabetes, according to a new study presented Sunday, June 12 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Male runners who are energy deficient may be at higher risk for fractures
Male runners who do not receive enough energy from their diet may be at risk for stress fractures, according to a new study presented Saturday, June 11 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Cost of mental health disorders linked with polycystic ovary syndrome almost $6 billion in 2021
The cost of mental health disorders associated with polycystic ovary syndrome (PCOS) – depression, anxiety and eating disorders – reached almost $6 billion in 2021, according to a new study presented Monday, June 13 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Chemicals in personal care products cause harmful effects in breast cancer cells from Black women
Chemicals called parabens, which are found in widely used hair and personal care products, cause harmful effects in breast cancer cells from Black women, according to a new study being presented Sunday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Unhealthy diet helps explain association between food insecurity and obesity
There is a greater prevalence of obesity and higher body fat among people who face food insecurity, according to research being presented Sunday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Endocrine-disrupting chemical exposure in womb impact fear, anxiety behavior in rats
Prenatal exposure to endocrine-disrupting chemicals found in everyday products may interfere with the developing offspring’s brain, according to a rat study being presented Monday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
AI can be used to identify benign thyroid nodules and reduce unnecessary biopsies
Artificial intelligence (AI) can be used to identify thyroid nodules seen on thyroid ultrasound that are very unlikely to be cancerous, reducing a large number of unnecessary biopsies, according to a new study being presented Saturday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Bias may play a role in underdiagnoses of prediabetes
The accurate diagnosis of prediabetes in the primary care setting might depend on a patient’s age, BMI, gender, race and certain comorbidities, according to research being presented at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Drinking coffee does not hinder the absorption of liquid thyroid medication
A new study conducted by Vertice Pharma confirms the absorption of an oral levothyroxine sodium solution (Thyquidity® 100g/ 5mL) was not affected by consuming coffee 5 minutes after the dose, according to research being presented Saturday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Probiotic bacteria may enhance tamoxifen effectiveness in treatment of ER+ breast cancer
Probiotic bacteria may enhance anti-cancer activities of the breast cancer drug tamoxifen and other endocrine-targeted therapies, which could help reduce the risk of estrogen receptive positive (ER+) breast cancer, suggests a new study presented Monday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Teens ate less ultra-processed food consumption during pandemic, reversing trend of three decades
For the first time in the last 30 years, the consumption of ultra-processed foods among teenagers in the United States declined during the COVID-19 pandemic, according to a new study presented at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
COVID-19 vaccination appears to be safe for patients treated for hypothyroidism
Inactivated and mRNA COVID-19 vaccines appear to be safe for patients treated for hypothyroidism,
according to a new study being presented at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga. The study found these vaccines do not cause significant fluctuations in thyroid function and are not associated with increased risks of emergency department visits or unscheduled hospitalizations.
Maintaining normal weight early in life may help prevent male infertility
New research suggests that more careful control of body weight in childhood and adolescence could help prevent male infertility later in life. The researchers will present their findings on Saturday, June 11 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.